Brown Advisory’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $536K | Hold |
114,698
| – | – | ﹤0.01% | 984 |
|
|
2025
Q1 | $630K | Sell |
114,698
-75,557
| -40% | -$415K | ﹤0.01% | 926 |
|
|
2024
Q4 | $645K | Hold |
190,255
| – | – | ﹤0.01% | 923 |
|
|
2024
Q3 | $542K | Hold |
190,255
| – | – | ﹤0.01% | 978 |
|
|
2024
Q2 | $428K | Hold |
190,255
| – | – | ﹤0.01% | 991 |
|
|
2024
Q1 | $420K | Sell |
190,255
-21,150
| -10% | -$46.7K | ﹤0.01% | 984 |
|
|
2023
Q4 | $497K | Sell |
211,405
-18,100
| -8% | -$42.5K | ﹤0.01% | 940 |
|
|
2023
Q3 | $427K | Sell |
229,505
-6,900
| -3% | -$12.8K | ﹤0.01% | 939 |
|
|
2023
Q2 | $619K | Hold |
236,405
| – | – | ﹤0.01% | 857 |
|
|
2023
Q1 | $385K | Hold |
236,405
| – | – | ﹤0.01% | 975 |
|
|
2022
Q4 | $314K | Sell |
236,405
-11,749
| -5% | -$15.6K | ﹤0.01% | 1018 |
|
|
2022
Q3 | $387K | Hold |
248,154
| – | – | ﹤0.01% | 919 |
|
|
2022
Q2 | $382K | Hold |
248,154
| – | – | ﹤0.01% | 906 |
|
|
2022
Q1 | $635K | Sell |
248,154
-51,600
| -17% | -$132K | ﹤0.01% | 806 |
|
|
2021
Q4 | $878K | Buy |
+299,754
| New | +$878K | ﹤0.01% | 753 |
|
|
2021
Q3 | – | Sell |
-299,754
| Closed | -$1.22M | – | 1144 |
|
|
2021
Q2 | $1.22M | Sell |
299,754
-20,000
| -6% | -$81.4K | ﹤0.01% | 659 |
|
|
2021
Q1 | $1.44M | Hold |
319,754
| – | – | ﹤0.01% | 639 |
|
|
2020
Q4 | $1.57M | Hold |
319,754
| – | – | ﹤0.01% | 580 |
|
|
2020
Q3 | $1.9M | Buy |
+319,754
| New | +$1.9M | ﹤0.01% | 524 |
|